The Japan Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) market is poised for significant growth, with its size projected to rise from USD 78.61 million in 2024 to USD 155.79 million by 2034, reflecting a compound annual growth rate (CAGR) of 7.10% over the forecast period. This market expansion is largely driven by increased awareness, advancements...